ArticleCureus2026
Isolated Splenic Metastasis With Perisplenic Artery Lymph Node Involvement More Than 10 Years After Curative Resection of Ascending Colon Cancer: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Splenic metastasis from colorectal cancer (CRC) is extremely rare, particularly as an isolated lesion, and most recurrences occur within five years. The presence of concurrent perisplenic artery lymph node metastases is unusual. A 71-year-old male who underwent right hemicolectomy for ascending colon adenocarcinoma (pT4aN0M0, Stage II) presented with elevated CA19-9 levels and a splenic tumor 10 years and 5 months after surgery. Imaging revealed a 9 × 8 cm splenic mass with suspected gastric wall invasion and swelling of the lymph node along the splenic artery. Positron emission tomography/computed tomography (PET/CT) confirmed high uptake in both lesions, and endoscopic ultrasound-guided fine-needle aspiration diagnosed adenocarcinoma. An open splenectomy with en bloc resection of the invaded gastric wall and No. 11p lymphadenectomy was performed. Pathology revealed a moderately differentiated adenocarcinoma in the spleen with gastric invasion and metastasis in the No. 11p lymph node. The patient recovered well after the surgery and completed adjuvant capecitabine chemotherapy. The patient remained recurrence-free six months postoperatively. This case highlights the exceptional rarity of isolated splenic metastasis appearing after more than 10 years of disease-free status, accompanied by perisplenic artery lymph node involvement. Splenic metastasis is believed to be prevented by anatomical and immunological mechanisms; however, splenectomy has demonstrated survival benefits. Concomitant lymph node metastasis suggests a potential lymphatic route of spread, and this postulated mechanism is supported by recent multicenter mapping of splenic flexural colon cancers. Splenic metastasis may occur even after long disease-free intervals, and splenectomy with lymphadenectomy can be both therapeutic and informative. Therefore, vigilance among long-term CRC survivors is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.